45 results on '"Chu, Felix"'
Search Results
2. Interviewing in Educational Research: A Bibliographic Essay.
- Author
-
Chu, Felix T.
- Abstract
Different types of interviews serve different purposes; however, they all share a common goal of collecting data in different situations. The data may be factual in generating quantitative input for a research project, attitudinal in gauging public acceptance of a proposed educational policy, or used in gaining a better understanding of a certain organizational feature of an educational institution. The normal progression in the interview process is from using open-ended questions as ice-breakers to establishing rapport with the interviewee, followed by negotiating the format, scope and range of the questions. Many researchers distinguish types of interviews by the amount of structure used in the process. Effective use of interviewing in qualitative research has also been discussed by researchers. Types of interviews applicable to educational research include: standardized survey interviews, in-depth interviews, intensive interviews, the long interview, the focused interview, and interviews of elites. Given the culturally diverse and heterogeneous population, problems and biases are becoming more apparent. Variables in the interview process include: race, gender, age, educational level, and social status. Because of cultural and linguistic variables, different people attach different degrees of importance to the value, worth or intent of certain questions and answers. Treating interviews as discourses and speech events open a whole new area for further research. Contains 31 references. (RS)
- Published
- 1993
3. Framing Reference Encounters.
- Author
-
Chu, Felix T.
- Abstract
Presents four frames to help understand library reference encounters, including the structural frame that uses rationality to establish procedures; the human resource frame, based on the satisfaction of needs in motivating people; the political frame that addresses allocation of resources; and the symbolic frame that assigns meaning to work. (Author/LRW)
- Published
- 1996
4. Reference Service and Bounded Rationality: Helping Students with Research.
- Author
-
Chu, Felix T.
- Abstract
In university libraries, reference librarians often get ambiguous questions to which they try to give appropriate answers. Because of limitations on resources, time, and mental capability for information processing, the decision-making process involved in answering reference questions becomes bounded by the rationality of these constraints. (Contains 10 references.) (Author/KRN)
- Published
- 1994
5. Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG
- Author
-
Wang, Xiangdan, Quarmby, Valerie, Ng, Carl, Chuntharapai, Anan, Shek, Theresa, Eigenbrot, Charles, Kelley, Robert F., Shia, Steven, McCutcheon, Krista, Lowe, John, Leddy, Cecilia, Coachman, Kyle, Cain, Gary, Chu, Felix, Hotzel, Isidro, Maia, Mauricio, Wakshull, Eric, and Yang, Jihong
- Published
- 2013
- Full Text
- View/download PDF
6. 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
- Author
-
Leung, Yvonne, primary, Vad, Nikhil, additional, Ye, Anne, additional, Santos, Daniel, additional, Cao, Wei, additional, Czupalla, Cathrin, additional, Vivian, John, additional, Williams, Carlene, additional, Sapugay, Judevin, additional, Harbell, Michael, additional, Lippow, Shaun, additional, Carroll, Chantia, additional, Kates, Lance, additional, Haugen, Benjamin, additional, Bolton, Gary, additional, Armanini, Mark, additional, Aydin, Iraz, additional, Whidden, Mark, additional, Velasco-Delgado, Mauricio, additional, Chu, Felix, additional, Wechsler, Erin, additional, Nguyen, Ngan, additional, Robinson, William, additional, Serafini, Tito, additional, Emerling, Daniel, additional, Greenberg, Norman, additional, Manning-Bog, Amy, additional, and Scholz, Alexander, additional
- Published
- 2020
- Full Text
- View/download PDF
7. 469 Cooperation between checkpoint inhibitors targeting the PD-1/PD-L1 axis and ATRC-101, a novel clinical-stage candidate for the treatment of solid tissue malignancies
- Author
-
Manning-Bog, Amy, primary, DeFalco, Jeff, additional, Scholz, Alexander, additional, Aydin, Iraz, additional, Vad, Nikhil, additional, Czupalla, Cathrin, additional, Chu, Felix, additional, Velasco-Delgado, Mauricio, additional, Harbell, Michael, additional, Lugar-Supagay, Judevin, additional, Leung, Yvonne, additional, Lippow, Shaun, additional, Ye, Anne, additional, Dhawan, Ish, additional, Baia, Gilson, additional, Wu, Dai-Chen, additional, Millward, Carl, additional, Whidden, Mark, additional, Benjamin, Jonathan, additional, Vivian, John, additional, Nguyen, Ngan, additional, Robinson, William, additional, Serafini, Tito, additional, Emerling, Daniel, additional, and Greenberg, Norman, additional
- Published
- 2020
- Full Text
- View/download PDF
8. CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis
- Author
-
Ziai, James, primary, Gilbert, Houston N., additional, Foreman, Oded, additional, Eastham-Anderson, Jeffrey, additional, Chu, Felix, additional, Huseni, Mahrukh, additional, and Kim, Jeong M., additional
- Published
- 2018
- Full Text
- View/download PDF
9. The Library Is More than a Heart
- Author
-
Chu, Felix T.
- Published
- 1994
10. Campbell's Call: Needed Change...
- Author
-
Chu, Felix T.
- Published
- 1993
11. Free Ambience Helps Research
- Author
-
Chu, Felix T.
- Published
- 1982
12. Bridging the LIS-practitioner gap: some frames for research
- Author
-
Chu, Felix T.
- Subjects
Library science -- Practice ,Libraries and readers -- Management ,Company business management ,Library and information science - Abstract
In his recent book, Spanning the Theory-Practice Divide in Library and Information Science, Bill Crowley (2005) examined the divide between published research from library school (LIS) faculty and the use [...]
- Published
- 2007
13. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma
- Author
-
Sahu, Nisebita, primary, Chan, Emily, additional, Chu, Felix, additional, Pham, Thinh, additional, Koeppen, Hartmut, additional, Forrest, William, additional, Merchant, Mark, additional, and Settleman, Jeff, additional
- Published
- 2017
- Full Text
- View/download PDF
14. Social aspects of information
- Author
-
Chu, Felix
- Subjects
United States. Library of Congress ,Library science ,Collection development (Libraries) ,Information services industry ,Information services ,Information services industry ,Library and information science - Abstract
Introduction In recent decades, institutions have been moving away from the positivism evident in many disciplines in the earlier years of the 20th century. Instead of seeking for a single [...]
- Published
- 2003
15. Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer
- Author
-
Ziai, James, primary, Gilbert, Houston, additional, Foreman, Oded, additional, Eastham-Anderson, Jeffrey, additional, Chu, Felix, additional, Huseni, Mahrukh, additional, and Kim, Jeong M, additional
- Published
- 2015
- Full Text
- View/download PDF
16. The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models
- Author
-
Foster, Paul, primary, Yamaguchi, Kyoko, additional, Hsu, Pin P., additional, Qian, Fawn, additional, Du, Xiangnan, additional, Wu, Jianming, additional, Won, Kwang-Ai, additional, Yu, Peiwen, additional, Jaeger, Christopher T., additional, Zhang, Wentao, additional, Marlowe, Charles K., additional, Keast, Paul, additional, Abulafia, Wendy, additional, Chen, Jason, additional, Young, Jenny, additional, Plonowski, Artur, additional, Yakes, F. Michael, additional, Chu, Felix, additional, Engell, Kelly, additional, Bentzien, Frauke, additional, Lam, Sanh T., additional, Dale, Stephanie, additional, Yturralde, Olivia, additional, Matthews, David J., additional, Lamb, Peter, additional, and Laird, A. Douglas, additional
- Published
- 2015
- Full Text
- View/download PDF
17. Immunohistochemical Detection of FLAG-Tagged Endogenous Proteins in Knock-In Mice
- Author
-
Ferrando, Ronald E., primary, Newton, Kim, additional, Chu, Felix, additional, Webster, Joshua D., additional, and French, Dorothy M., additional
- Published
- 2015
- Full Text
- View/download PDF
18. A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer
- Author
-
Ziai, James, primary, Huseni, Mahrukh, additional, Foreman, Oded, additional, Eastham-Anderson, Jeffrey, additional, Xiao, Yuanyuan, additional, Chu, Felix, additional, Kowanetz, Marcin, additional, Hegde, Priti S, additional, and Kim, Jeong, additional
- Published
- 2014
- Full Text
- View/download PDF
19. Characterization of the Activity of the PI3K/mTOR Inhibitor XL765 (SAR245409) in Tumor Models with Diverse Genetic Alterations Affecting the PI3K Pathway
- Author
-
Yu, Peiwen, primary, Laird, A. Douglas, additional, Du, Xiangnan, additional, Wu, Jianming, additional, Won, Kwang-Ai, additional, Yamaguchi, Kyoko, additional, Hsu, Pin Pin, additional, Qian, Fawn, additional, Jaeger, Christopher T., additional, Zhang, Wentao, additional, Buhr, Chris A., additional, Shen, Paula, additional, Abulafia, Wendy, additional, Chen, Jason, additional, Young, Jenny, additional, Plonowski, Arthur, additional, Yakes, F. Michael, additional, Chu, Felix, additional, Lee, Michelle, additional, Bentzien, Frauke, additional, Lam, Sanh Tan, additional, Dale, Stephanie, additional, Matthews, David J., additional, Lamb, Peter, additional, and Foster, Paul, additional
- Published
- 2014
- Full Text
- View/download PDF
20. Social Aspects of Information
- Author
-
Chu, Felix T and Chu, Felix T
- Published
- 2005
21. Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- Author
-
Yakes, F. Michael, primary, Chen, Jason, additional, Tan, Jenny, additional, Yamaguchi, Kyoko, additional, Shi, Yongchang, additional, Yu, Peiwen, additional, Qian, Fawn, additional, Chu, Felix, additional, Bentzien, Frauke, additional, Cancilla, Belinda, additional, Orf, Jessica, additional, You, Andrew, additional, Laird, A. Douglas, additional, Engst, Stefan, additional, Lee, Lillian, additional, Lesch, Justin, additional, Chou, Yu-Chien, additional, and Joly, Alison H., additional
- Published
- 2011
- Full Text
- View/download PDF
22. Navigating the wilderness: Another view of the information landscape
- Author
-
Chu, Felix, primary
- Published
- 2011
- Full Text
- View/download PDF
23. A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2
- Author
-
Eder, Joseph Paul, primary, Shapiro, Geoffrey I., additional, Appleman, Leonard J., additional, Zhu, Andrew X., additional, Miles, Dale, additional, Keer, Harold, additional, Cancilla, Belinda, additional, Chu, Felix, additional, Hitchcock-Bryan, Suzanne, additional, Sherman, Laurie, additional, McCallum, Stewart, additional, Heath, Elisabeth I., additional, Boerner, Scott A., additional, and LoRusso, Patricia M., additional
- Published
- 2010
- Full Text
- View/download PDF
24. Abstract B269: Pharmacodynamic and correlative biomarker analyses in clinical trials of XL184, an oral, potent inhibitor of MET, VEGFR2, and RET
- Author
-
Müller, Thomas, primary, DePrimo, Samuel, additional, McGrath, Garth, additional, Yu, Peiwen, additional, Wu, Jianming, additional, Goon, Levina, additional, Lee, Michelle, additional, de Costa, Anushka, additional, Chu, Felix, additional, Cancilla, Belinda, additional, Huang, Stephen, additional, Vysotskaia, Valentina, additional, Li, Jonathan, additional, Zhao, Lora, additional, and Wong, Mei, additional
- Published
- 2009
- Full Text
- View/download PDF
25. On considering microcomputer software for purchase
- Author
-
Chu, Felix
- Subjects
Public Libraries ,Libraries ,Software Selection ,Software - Published
- 1986
26. Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647
- Author
-
Gendreau, Steven B., primary, Ventura, Richard, additional, Keast, Paul, additional, Laird, A. Douglas, additional, Yakes, F. Michael, additional, Zhang, Wentao, additional, Bentzien, Frauke, additional, Cancilla, Belinda, additional, Lutman, Jeffery, additional, Chu, Felix, additional, Jackman, Lisa, additional, Shi, Yongchang, additional, Yu, Peiwen, additional, Wang, Jing, additional, Aftab, Dana T., additional, Jaeger, Christopher T., additional, Meyer, Stephanie M., additional, De Costa, Anushka, additional, Engell, Kelly, additional, Chen, Jason, additional, Martini, Jean-Francois, additional, and Joly, Alison H., additional
- Published
- 2007
- Full Text
- View/download PDF
27. The Way I See It: Another look at staffing the reference desk
- Author
-
Chu, Felix, primary
- Published
- 1997
- Full Text
- View/download PDF
28. Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG.
- Author
-
Xiangdan Wang, Quarmby, Valerie, Ng, Carl, Chuntharapai, Anan, Shek, Theresa, Eigenbrot, Charles, Kelley, Robert F., Shia, Steven, McCutcheon, Krista, Lowe, John, Leddy, Cecilia, Coachman, Kyle, Cain, Gary, Chu, Felix, Hotzel, Isidro, Maia, Mauricio, Wakshull, Eric, and Jihong Yang
- Published
- 2013
- Full Text
- View/download PDF
29. Navigating the wilderness.
- Author
-
Chu, Felix
- Subjects
- *
LIBRARIANS , *STUDENTS , *INTERNET searching , *ELECTRONIC information resource searching , *COMPUTER network resources , *ELECTRONIC information resources - Abstract
The author calls upon librarians to help students navigate through the information landscape when searching materials on the Web. He thinks that the wilderness, which is one of the two basic worldviews face by librarians, is closer to the view of the information landscape because of the abundance of Web resources. He emphasizes the need to improvise to create plausible and feasible solutions in order to make the information landscape a process of sensemaking. He reminds librarians to use their knowledge base and experiences to improvise a strategy.
- Published
- 2011
- Full Text
- View/download PDF
30. "Useful" isn't always "usable"
- Author
-
Chu, Felix T.
- Subjects
- *
LETTERS to the editor , *INFORMATION services - Abstract
Presents a letter to the editor responding to the March 1st article "Reclaiming Our Technological Future," which focused on accessing information on library computers.
- Published
- 1990
31. Another look at staffing the reference desk.
- Author
-
Chu, Felix
- Subjects
- *
ACADEMIC libraries - Abstract
Argues that it is not appropriate for academic libraries, to use graduate students or clerical staff at the reference desk. Perception that this would undermine the quality of undergraduate education; Reason for the decision to use graduate students, and clerical staff.
- Published
- 1997
32. Staphylococcus capitis isolated from bloodstream infections: a nationwide 3-month survey in 38 neonatal intensive care units
- Author
-
Sylvie Joron, Stéphane Marret, Fabrice Lapeyre, Jérôme Larche, Jacqueline Grando, David Leyssene, Jean Nakhleh, Clarisse Dupin, Tania Foucan, Stéphanie Bordes-Couecou, Géraldine Abadie, Franck Labbe, Marie Kempf, Manuel Petitfrere, Audrey Robine, Marie Decalonne, Chantal Chaplain, Philippe Jouvencel, Florent Goube, Benjamin Cotte, Laurent Villeneuve, Adeline Lacazette, Raoul Baron, Jean-Marc Jellimann, Anne-Sophie Trentesaux, Nathalie Chautemps, Laurent Mereghetti, Olivier Dauwalder, Nicolas Fortineau, Christine Roques Ceschin, Rafik Ben Ammar, Sandra Bourdon, Alain Gravet, Audrey Glanard, Olivier Belmonte, Jacques Gilquin, Arnaud Florentin, Souad Slimani, Annick Lefebvre, Jérôme Guinard, Edith Malpote, Céline Chatelet, Isabelle Bauvin, Alain Lozniewski, Anaëlle Muggeo, Geneviève Héry-Arnaud, Stéphane Le Vu, Isabelle Ligi, Anne Le Pourhiennec, Christian Cattoen, Olivier Join-Lambert, Bruno Pozetto, Carole De Chillaz, Amine Siali, Pascale Martres, Michel Drancourt, Claire Lesteven, Sandra C. dos Santos, Nadège Bourgeois-Nicolaos, Aude Davy, Claude Olive, Rémi Gimenes, Laure Gibert, Raymond Ruimy, Virginie Morange, Antoine Bouissou, Julien Mourdie, Emmanuelle Bille, Marie-Noëlle Noulard, Vincent Cattoir, Martine Delorme, Dominique Trivier, Luc Desfrere, Hugues Patural, Patrick Barthelemy, Nadia Idri, Florence Lemann, Franck-Olivier Mallaval, Sophie Ketterer-Martinon, Christian Vandenbussche, Pierre Frange, Sylvie Ledru, Mouna Khecharem, Pierre Lureau, Sophie Boyer, Philippe Berthelot, Salma Ben Hadj Yahia, Clément Legeay, Emilie Benabid, Guillaume Menard, Marion Levast-Raffin, Céline Coroller-Bec, Claire Huart, Maryvonne Demasure, Pascal Bolot, Yasmina Berrouane, Hélène Cormier, Pascale Minery, Pascale Penn, Peggy Larroude, Evelyne Werner, Géraldine Gascoin, Virginie Forget, Nathalie van der Mee-Marquet, Stéphanie Soive, Karine Gambarotto, Vanina Ambrogi, Aurore Claudinon, Serge Klosowski, Brigitte Riviere, Véronique Merle, Laura Menvielle, Véronique Faraut-Derouin, Saïd Aberrane, Alain Beuchee, Nolwenn Le Sache, Hôpital Bretonneau, CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre hospitalier Félix-Guyon [Saint-Denis, La Réunion], Centre Hospitalier René Dubos [Pontoise], Centre Hospitalier Intercommunal de Créteil (CHIC), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Centre hospitalier de Pau, Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier de Calais, Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), CHU Pontchaillou [Rennes], Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier de Saint-Denis [Ile-de-France], Centre Hospitalier de la Côte Basque (CHCB), Groupe Hospitalier du Havre, Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Centre hospitalier [Valenciennes, Nord], Centre Hospitalier Universitaire [Rennes], GHT de l'Artois, Centre Hospitalier Victor Dupouy, Centre Hospitalier Métropole Savoie [Chambéry], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre Hospitalier Le Mans (CH Le Mans), Clinique du Val d'Ouest, CHU Necker - Enfants Malades [AP-HP], Hospices Civils de Lyon (HCL), Centre hospitalier Saint-Brieuc, Centre Hospitalier Georges Renon [Niort] (CH Georges Renon Niort), Centre Hospitalier Régional d'Orléans (CHRO), Hôpital Louis Mourier - AP-HP [Colombes], Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), CHU de Saint-Brieuc, Interactions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), Université de Lorraine (UL), Unité de Recherche Environnement Physique de la plante Horticole (EPHOR), Université d'Angers (UA)-AGROCAMPUS OUEST, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), CHU Pointe-à-Pitre/Abymes [Guadeloupe], Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Hôpital Hôtel-Dieu [Paris], Hôpital Delafontaine, Centre Hospitalier de Mulhouse, site du Hasenrain (Mulhouse), Laboratoire Universitaire de Biodiversité et Ecologie Microbienne (LUBEM), Université de Brest (UBO), Service de réanimation néonatale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Pathogénie des infections systémiques (UMR_S 570), Centre Régional de PharmacoVigilance Nord-Pas-de-Calais [CHU Lille] (CRPV), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Faculté de Médecine Henri Warembourg - Université de Lille, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), CHU de la Martinique [Fort de France], Groupe Hospitalier du Havre Hôpital Jacques Monod (MONTIVILLIERS) (GHH), Polyclinique Médipôle Saint-Roch [Cabestany], Centre Hospitalier Universitaire de Reims (CHU Reims), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Université d'Auvergne - Clermont-Ferrand I (UdA), Aix-Marseille Université - École de médecine (AMU SMPM MED), Aix-Marseille Université - Faculté des sciences médicales et paramédicales (AMU SMPM), Aix Marseille Université (AMU)-Aix Marseille Université (AMU), Service de microbiologie [CHU Nancy], Service psychiatrique de l'enfant et de l'adolescent [CHU Hôpital Robert Debré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré, Service de bactériologie-virologie [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Infectiologie et Santé Publique (UMR ISP), Université de Tours (UT)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Registre EPIMAD, Normandie Université (NU)-Normandie Université (NU)-CHU Amiens-Picardie-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Pathogénie des Staphylocoques – Staphylococcal Pathogenesis (StaPath), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Groupe Hospitalier Artois-Ternois Centre Hospitalier d’Arras, Système Nerveux Autonome - Epidémiologie, Physiologie, Ingénierie, Santé (SNA - EPIS), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)-Université Jean Monnet - Saint-Étienne (UJM), ELSAN Polyclinique Majorelle, Centre Hospitalier Intercommunal Castres-Mazamet (CHIC-CM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Centre Hospitalier de Lens, Institut de Veille Sanitaire (INVS), Hôpital Trousseau, Jonchère, Laurent, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Le CHCB, Centre Hospitalier de la Côte Basque, Centre International de Recherche en Infectiologie - UMR (CIRI), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Système Nerveux Autonome - Epidémiologie, Physiologie, Ingénierie, Santé (SNA-EPIS), Université Jean Monnet - Saint-Étienne (UJM)-Centre Hospitalier Universitaire de Saint-Etienne, CHU Saint-Etienne, Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Université de Caen Normandie (UNICAEN), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université Lille 2 - Faculté de Médecine, Université de Tours-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Amiens-Picardie, Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Université Jean Monnet [Saint-Étienne] (UJM)-Centre Hospitalier Universitaire de Saint-Etienne, CHU Toulouse [Toulouse], Centre Hospitalier Universitaire Félix-Guyon [Saint-Denis, La Réunion, France], Centre Hospitalier Universitaire de Toulouse, Department of Microbiology Brest, Department of Microbiology, Brest, CHU CLAMART, Centre Hospitalier Universitaire de Nice (CHU de Nice), Centre Hospitalier Côte Basque, Bayonne, CHU Le Havre, Laboratory of microbiology and infection control, Assistance publique-Hôpitaux de Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire Charles Nicolle, Partenaires INRAE, CHU de la Réunion, Saint-Denis, France., CHU Lens, CHU Argenteuil, Centre Hospitalier Métropole Savoie-Site de Chambéry, La Clinique du Val d'Ouest, Hôpitaux Est Hôpital Louis Pradel - Hospices Civils de Lyon, Centre Hospitalier Régional d'Orléans (CHR), Hopital Louis Mourier - AP-HP [Colombes], Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU), Service de virologie, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CHU Pontchaillou [Rennes], Hôpital Antoine Béclère, Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Bactériologie-Virologie, Hôpital Bretonneau-Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre d'infectiologie Necker-Pasteur [CHU Necker], Service de chirurgie infantile, CHU Felix Guyon, Saint Denis de La Réunion, Hôtel-Dieu, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôtel-Dieu, Unité d'Hygiène Hospitalière, hospices civils de Lyon, Hôpital du Hasenrain, Mulhouse, CHU Valenciennes, Université Henri Poincaré - Nancy 1 (UHP), Hôpital de Bayonne [Bayonne], CHU Kremlin-Bicétre, Anofel Cryptosporidium National Network, Polyclinique de St Roch, CHU Pau, Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Division of Neonatology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille and Faculté de Médecine, Université de la Méditerranée - Aix-Marseille 2, Laboratoire de Microbiologie clinique et environnementale [Pointe-à-Pitre, Guadeloupe, France], Centre Hospitalier Universitaire de Rennes (CHU Rennes), Hôpital privé de l'Estuaire [Le Havre], Pathogénie des Staphylocoques – Staphylococcal Pathogenesis, Hôpital d'Arras, CHU Le MAns, Polyclinique Majorelle, Laboratoire de Microbiologie, Centre Hospitalier Intercommunal Castres-Mazamet, Laboratoire de bactériologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 (UPD7), Laboratoire de Recherche Opérationnelle et Mathématiques de la Décision - LAROMAD (Alger, Algérie), Centre Hospitalier d’Arras, Unité de Méthodologie en Recherche Clinique, Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)
- Subjects
Male ,0301 basic medicine ,Pediatrics ,Clone (cell biology) ,NRCS-A clone ,030501 epidemiology ,Staphylococcus capitis ,Medical microbiology ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Drug Resistance, Multiple, Bacterial ,Medicine ,[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,biology ,Brief Report ,Gestational age ,General Medicine ,Staphylococcal Infections ,Anti-Bacterial Agents ,3. Good health ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Nationwide active surveillance ,Infectious Diseases ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Vancomycin ,Female ,France ,0305 other medical science ,Infant, Premature ,[SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology ,medicine.drug ,Microbiology (medical) ,medicine.medical_specialty ,Bloodstream catheter-related infection ,Birth weight ,Preterm babies ,030106 microbiology ,Late onset ,03 medical and health sciences ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Intensive Care Units, Neonatal ,Sepsis ,Intensive care ,Humans ,[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology ,business.industry ,Neonatal Intensive Care Unit (NICU) ,Infant, Newborn ,Neonates ,biology.organism_classification ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,Catheter-Related Infections ,[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,business - Abstract
To increase the knowledge about S. capitis in the neonatal setting, we conducted a nationwide 3-month survey in 38 neonatal intensive care units (NICUs) covering 56.6% of French NICU beds. We demonstrated 14.2% of S. capitis BSI (S.capBSI) among nosocomial BSIs. S.capBSI incidence rate was 0.59 per 1000 patient-days. A total of 55.0% of the S.capBSIs were late onset catheter-related BSIs. The S. capitis strains infected preterm babies (median gestational age 26 weeks, median birth weight 855 g). They were resistant to methicillin and aminoglycosides and belonged to the NRCS-A clone. Evolution was favorable in all but one case, following vancomycin treatment.
- Published
- 2020
33. Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy.
- Author
-
Zborowsky S, Seurat J, Balacheff Q, Ecomard S, Nguyen Ngoc Minh C, Titécat M, Evrard E, Rodriguez-Gonzalez RA, Marchi J, Weitz JS, and Debarbieux L
- Abstract
The rise of antimicrobial resistance has led to renewed interest in evaluating phage therapy. In murine models highly effective treatment of acute pneumonia caused by Pseudomonas aeruginosa relies on the synergistic antibacterial activity of bacteriophages with neutrophils. Here, we show that depletion of alveolar macrophages (AM) shortens the survival of mice without boosting the P . aeruginosa load in the lungs. Unexpectedly, upon bacteriophage treatment, pulmonary levels of P. aeruginosa were significantly lower in AM-depleted than in immunocompetent mice. To explore potential mechanisms underlying the benefit of AM-depletion in treated mice, we developed a mathematical model of phage, bacteria, and innate immune system dynamics. Simulations from the model fitted to data suggest that AM reduce bacteriophage density in the lungs. We experimentally confirmed that the in vivo decay of bacteriophage is faster in immunocompetent compared to AM-depleted animals. These findings demonstrate the involvement of feedback between bacteriophage, bacteria, and the immune system in shaping the outcomes of phage therapy in clinical settings., Competing Interests: DECLARATION OF INTERESTS The authors declare no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
34. Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection.
- Author
-
Rodriguez-Gonzalez RA, Balacheff Q, Debarbieux L, Marchi J, and Weitz JS
- Abstract
Infections caused by multi-drug resistant (MDR) pathogenic bacteria are a global health threat. Phage therapy, which uses phage to kill bacterial pathogens, is increasingly used to treat patients infected by MDR bacteria. However, the therapeutic outcome of phage therapy may be limited by the emergence of phage resistance during treatment and/or by physical constraints that impede phage-bacteria interactions in vivo . In this work, we evaluate the role of lung spatial structure on the efficacy of phage therapy for Pseudomonas aeruginosa infection. To do so, we developed a spatially structured metapopulation network model based on the geometry of the bronchial tree, and included the emergence of phage-resistant bacterial mutants and host innate immune responses. We model the ecological interactions between bacteria, phage, and the host innate immune system at the airway (node) level. The model predicts the synergistic elimination of a P. aeruginosa infection due to the combined effects of phage and neutrophils given sufficiently active immune states and suitable phage life history traits. Moreover, the metapopulation model simulations predict that local MDR pathogens are cleared faster at distal nodes of the bronchial tree. Notably, image analysis of lung tissue time series from wild-type and lymphocyte-depleted mice (n=13) revealed a concordant, statistically significant pattern: infection intensity cleared in the bottom before the top of the lungs. Overall, the combined use of simulations and image analysis of in vivo experiments further supports the use of phage therapy for treating acute lung infections caused by P. aeruginosa while highlighting potential limits to therapy given a spatially structured environment, such as impaired innate immune responses and low phage efficacy.
- Published
- 2024
- Full Text
- View/download PDF
35. RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models.
- Author
-
Morel G, Ernest S, Serey-Gaut M, Jonard L, Balogoun AR, Parodi M, Loundon N, Achard S, and Marlin S
- Subjects
- Mice, Animals, Humans, Zebrafish, Disease Models, Animal, Hearing Loss, Sensorineural genetics, Bilateral Vestibulopathy
- Abstract
Cochleovestibular dysfunctions are rare conditions misrecognized. A homozygous pathogenic variation c.1561C > T (p.Arg521*) in RIPOR2 (RHO family interacting cell polarization regulator 2) has been identified by WES in Tunisian siblings suffering from congenital bilateral profound hearing and vestibular dysfunctions. In contrast to the vestibular areflexia observed in our patients, deaf Ripor2 KO mouse model and our zebrafish model have normal vestibular function., (© 2023 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
36. Dengue Virus in Kidney Allograft: Implications for Donor Screening and Viral Reservoir.
- Author
-
Di Ascia L, Jaffar-Bandjee MC, Cresta MP, Vasseur AS, Lugagne N, Vacher-Coponat H, and Gosset C
- Published
- 2023
- Full Text
- View/download PDF
37. Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial.
- Author
-
Sharshar T, Porcher R, Asfar P, Grimaldi L, Jabot J, Argaud L, Lebert C, Bollaert PE, Harlay ML, Chillet P, Maury E, Santoli F, Blanc P, Sonneville R, Vu DC, Rohaut B, Mazeraud A, Alvarez JC, Navarro V, Clair B, and Outin H
- Subjects
- Adult, Humans, Hospitalization, Patient Discharge, Administration, Intravenous, Valproic Acid therapeutic use, Benzodiazepines
- Abstract
Background: Generalised convulsive status epilepticus (GCSE) is a medical emergency. Guidelines recommend a stepwise strategy of benzodiazepines followed by a second-line anti-seizure medicine (ASM). However, GCSE is uncontrolled in 20-40% patients and is associated with protracted hospitalisation, disability, and mortality. The objective was to determine whether valproic acid (VPA) as complementary treatment to the stepwise strategy improves the outcomes of patients with de novo established GCSE., Methods: This was a multicentre, double-blind, randomised controlled trial in 244 adults admitted to intensive care units for GCSE in 16 French hospitals between 2013 and 2018. Patients received standard care of benzodiazepine and a second-line ASM (except VPA). Intervention patients received a 30 mg/kg VPA loading dose, then a 1 mg/kg/h 12 h infusion, whilst the placebo group received an identical intravenous administration of 0.9% saline as a bolus and continuous infusion. Primary outcome was proportion of patients discharged from hospital by day 15. The secondary outcomes were seizure control, adverse events, and cognition at day 90., Results: A total of 126 (52%) and 118 (48%) patients were included in the VPA and placebo groups. 224 (93%) and 227 (93%) received a first-line and a second-line ASM before VPA or placebo infusion. There was no between-group difference for patients hospital-discharged at day 15 [VPA, 77 (61%) versus placebo, 72 (61%), adjusted relative risk 1.04; 95% confidence interval (0.89-1.19); p = 0.58]. There were no between-group differences for secondary outcomes., Conclusions: VPA added to the recommended strategy for adult GCSE is well tolerated but did not increase the proportion of patients hospital-discharged by day 15., Trial Registration No: NCT01791868 (ClinicalTrials.gov registry), registered: 15 February 2012., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
38. Medical analysis of the contribution of sialendoscopy in managing non-tumoral main salivary gland pathology in Reunion Island: Observational study following STROBE guidelines.
- Author
-
Delagranda A, Bohrer M, Ferdynus C, Waubant A, Dufour X, and Rubin F
- Subjects
- Humans, Middle Aged, Parotid Gland, Retrospective Studies, Reunion, Salivary Glands, Treatment Outcome, Endoscopy methods, Salivary Gland Calculi surgery
- Abstract
Goals: To perform a medical analysis of the contribution of sialendoscopy in the treatment of non-tumoral pathologies of the main salivary glands, in Reunion Island, a French overseas territory., Material and Method: A multicenter retrospective observational study was conducted for an 8-year period, before and after introduction of sialendoscopy (2011-2014 and 2015-2018), following STROBE guidelines., Objectives: To compare populations treated before (period A) and after (period B) the introduction of sialendoscopy in terms of clinical characteristics, and analyze the characteristics of patients treated by sialendoscopy., Results: Two hundred and sixty-five patients were included: 74 in 2011-2014 and 191 in 2015-2018; 139 had sialendoscopy. Populations A and B were comparable except for the proportion of parotids treated (9% vs. 31%, respectively; P<0.0001), and smaller stones (11mm vs. 7.4mm, respectively; P=0.003). One hundred and ten pure sialendoscopies and 29 combined routes (20.8%) were performed: 63% submandibular and 37% parotid. Median age was 46 years. The M/F sex ratio was 0.96. Thirty-seven patients presented stenosis. There were 10 cases of papillary catheterization failure (7.1%), and 16 false routes or creation of false channels (11.5%), including 9 during the learning period. The rate of crossover to gland resection decreased: 10.45% for 2015-2016 and 5.56% for 2017-2018., Conclusion: Although follow-up ranged between 12 and 55months (median, 30months), sialendoscopy appeared to be a useful and reliable technique, with a role in therapeutic strategy for the management of non-tumoral salivary pathologies in Reunion Island., (Copyright © 2021 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
39. Effects of local cryotherapy on systemic endothelial activation, dysfunction, and vascular inflammation in adjuvant-induced arthritis (AIA) rats.
- Author
-
Peyronnel C, Totoson P, Petitcolin V, Bonnefoy F, Guillot X, Saas P, Verhoeven F, Martin H, and Demougeot C
- Subjects
- Animals, Cryotherapy, Inflammation, Interleukin-17, Interleukin-6, RNA, Messenger, Rats, Rats, Inbred Lew, Tumor Necrosis Factor-alpha, Arthritis, Experimental, Intercellular Adhesion Molecule-1
- Abstract
Aim: This study explored the systemic vascular effects of local cryotherapy with a focus on endothelial changes and arterial inflammation in the model of rat adjuvant-induced arthritis (AIA)., Methods: Cryotherapy was applied twice a day on hind paws of AIA rats from the onset of arthritis to the acute inflammatory phase. Endothelial activation was studied in the aorta by measuring the mRNA levels of chemokines (CXCL-1, MCP-1 (CCL-2), MIP-1α (CCL-3)) and adhesion molecules (ICAM-1, VCAM-1) by qRT-PCR. Endothelial dysfunction was measured in isolated aortic and mesenteric rings. Aortic inflammation was evaluated via the mRNA expression of pro-inflammatory cytokines (TNF-α, IL-6) by qRT-PCR and leucocyte infiltration analysis (flow cytometry). Plasma levels of TNF-α, IL-6, IL-1β, IL-17A, and osteoprotegerin (OPG) were measured using Multiplex/ELISA., Results: AIA was associated with an increased aortic expression of CXCL-1 and ICAM-1 as well as an infiltration of leucocytes and increased mRNA expression of IL-6, IL-1β, and TNF-α. Local cryotherapy, which decreased arthritis score and structural damages, reduced aortic mRNA expression of CXCL-1, IL-6, IL-1β, and TNF-α, as well as aortic infiltration of leucocytes (T lymphocytes, monocytes/macrophages, neutrophils) and improved acetylcholine-induced vasorelaxation in the aorta and mesenteric arteries. Plasma levels of IL-17A and OPG were significantly reduced by cryotherapy, while the number of circulating leucocytes was not. IL-17A levels positively correlated with endothelial activation and dysfunction., Conclusion: In the AIA model, local cryotherapy reduced systemic endothelial activation, immune cell infiltration, and endothelial dysfunction. Mechanistically, the reduction of circulating levels of IL-17A appears as the possible link between joint cooling and the remote vascular effects., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
40. Clinical and neuroimaging findings in 33 patients with MCAP syndrome: A survey to evaluate relevant endpoints for future clinical trials.
- Author
-
Garde A, Guibaud L, Goldenberg A, Petit F, Dard R, Roume J, Mazereeuw-Hautier J, Chassaing N, Lacombe D, Morice-Picard F, Toutain A, Arpin S, Boccara O, Touraine R, Blanchet P, Coubes C, Willems M, Pinson L, Van Kien PK, Chiaverini C, Giuliano F, Alessandri JL, Mathieu-Dramard M, Morin G, Bursztejn AC, Mignot C, Doummar D, Di Rocco F, Cornaton J, Nicolas C, Gautier E, Luu M, Bardou M, Sorlin A, Philippe C, Edery P, Rossi M, Carmignac V, Thauvin-Robinet C, Vabres P, and Faivre L
- Subjects
- Abnormalities, Multiple drug therapy, Adolescent, Adult, Child, Child, Preschool, Class I Phosphatidylinositol 3-Kinases genetics, Cohort Studies, Female, Forecasting, Humans, Magnetic Resonance Imaging, Male, Megalencephaly drug therapy, Skin Diseases, Vascular drug therapy, Telangiectasis diagnostic imaging, Telangiectasis drug therapy, Telangiectasis physiopathology, Young Adult, Abnormalities, Multiple diagnostic imaging, Abnormalities, Multiple physiopathology, Clinical Trials as Topic, Megalencephaly diagnostic imaging, Megalencephaly physiopathology, Neuroimaging, Skin Diseases, Vascular diagnostic imaging, Skin Diseases, Vascular physiopathology, Telangiectasis congenital
- Abstract
Megalencephaly-CApillary malformation-Polymicrogyria (MCAP) syndrome results from somatic mosaic gain-of-function variants in PIK3CA. Main features are macrocephaly, somatic overgrowth, cutaneous vascular malformations, connective tissue dysplasia, neurodevelopmental delay, and brain anomalies. The objectives of this study were to describe the clinical and radiological features of MCAP, to suggest relevant clinical endpoints applicable in future trials of targeted drug therapy. Based on a French collaboration, we collected clinical features of 33 patients (21 females, 12 males, median age of 9.9 years) with MCAP carrying mosaic PIK3CA pathogenic variants. MRI images were reviewed for 21 patients. The main clinical features reported were macrocephaly at birth (20/31), postnatal macrocephaly (31/32), body/facial asymmetry (21/33), cutaneous capillary malformations (naevus flammeus 28/33, cutis marmorata 17/33). Intellectual disability was present in 15 patients. Among the MRI images reviewed, the neuroimaging findings were megalencephaly (20/21), thickening of corpus callosum (16/21), Chiari malformation (12/21), ventriculomegaly/hydrocephaly (10/21), cerebral asymmetry (6/21) and polymicrogyria (2/21). This study confirms the main known clinical features that defines MCAP syndrome. Taking into account the phenotypic heterogeneity in MCAP patients, in the context of emerging clinical trials, we suggest that patients should be evaluated based on the main neurocognitive expression on each patient., (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
41. Acute severe asthma requiring invasive mechanical ventilation in the era of modern resuscitation techniques: A 10-year bicentric retrospective study.
- Author
-
Binachon A, Grateau A, Allou N, Ferdynus C, Allyn J, Dangers L, Martinet O, Boisson V, Gauthier A, Jabot J, and Persichini R
- Subjects
- Acute Disease, Adult, Aged, Asthma mortality, Female, Hospital Mortality, Humans, Intensive Care Units statistics & numerical data, Male, Middle Aged, Patient Admission statistics & numerical data, Retrospective Studies, Risk Factors, Asthma therapy, Respiration, Artificial, Resuscitation
- Abstract
Purpose: Patients with acute severe asthma (ASA) may in rare cases require invasive mechanical ventilation (IMV). However, recent data on this issue are lacking., Materials and Methods: In this retrospective and bicentric study conducted on a 10 year period, we investigate the in-hospital mortality in patients with ASA requiring IMV. We compare this mortality to that of patients with other types of respiratory distress using a standardized mortality ratio (SMR) model., Results: Eighty-one episodes of ASA requiring IMV were evaluated. Factors significantly associated with in-hospital mortality were cardiac arrest on day of admission, cardiac arrest as the reason for intubation, absence of decompensation risk factors, need for renal replacement therapy on day of admission, and intubation in pre-hospital setting. Non-survivors had higher SAPS II, SOFA, creatinine and lactate levels as well as lower blood pressure, pH, and HCO3 on day of admission. In-hospital mortality was 15% (n = 12). Compared to a reference population of 2,670 patients, the SMR relative to the SAPS II was very low at 0.48 (95% CI, 0.25-0.84). The only factor independently associated with in-hospital mortality was cardiac arrest on day of admission. In-hospital mortality was 69% in patients with cardiac arrest on day of admission and 4% in others (p < 0.01). Salvage therapies were given to 7 patients, sometimes in combination with each other: ECMO (n = 6), halogenated gas (n = 1) and anti-IL5 antibody (n = 1). Death occurred in only 2 of these 7 patients, both of whom had cardiac arrest on day of admission., Conclusion: Nowadays, the mortality of patients with ASA requiring IMV is low. Death is due to multi-organ failure, with cardiac arrest on day of admission being the most important risk factor. In patients who did not have cardiac arrest on day of admission the mortality is even lower (4%) which allows an aggressive management., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
42. Treatment and outcome of congenital nephrotic syndrome.
- Author
-
Bérody S, Heidet L, Gribouval O, Harambat J, Niaudet P, Baudouin V, Bacchetta J, Boudaillez B, Dehennault M, de Parscau L, Dunand O, Flodrops H, Fila M, Garnier A, Louillet F, Macher MA, May A, Merieau E, Monceaux F, Pietrement C, Rousset-Rouvière C, Roussey G, Taque S, Tenenbaum J, Ulinski T, Vieux R, Zaloszyc A, Morinière V, Salomon R, and Boyer O
- Subjects
- Disease Progression, Female, France epidemiology, Humans, Incidence, Infant, Infant, Newborn, Male, Nephrotic Syndrome epidemiology, Nephrotic Syndrome genetics, Nephrotic Syndrome therapy, Retrospective Studies, Survival Rate, Treatment Outcome, Membrane Proteins genetics, Mutation, Nephrectomy mortality, Nephrotic Syndrome mortality
- Abstract
Background: Recommendations for management of Finnish-type congenital nephrotic syndrome (CNS) followed by many teams include daily albumin infusions, early bilateral nephrectomy, dialysis and transplantation. We aimed to assess the treatment and outcome of patients with CNS in France., Methods: We conducted a nationwide retrospective study on 55 consecutive children born between 2000 and 2014 treated for non-infectious CNS., Results: The estimated cumulative incidence of CNS was 0.5/100 000 live births. The underlying defect was biallelic mutations in NPHS1 (36/55, 65%), NPHS2 (5/55, 7%), PLCE1 (1/55, 2%), heterozygous mutation in WT1 (4/55, 7%) and not identified in nine children (16%). Fifty-three patients (96%) received daily albumin infusions from diagnosis (median age 14 days), which were spaced and withdrawn in 10 patients. Twenty children (35%) were managed as outpatients. Thirty-nine patients reached end-stage kidney disease (ESKD) at a median age of 11 months. The overall renal survival was 64% and 45% at 1 and 2 years of age, respectively. Thirteen children died during the study period including four at diagnosis, two of nosocomial catheter-related septic shock, six on dialysis and one after transplantation. The remaining 13 patients were alive with normal renal function at last follow-up [median 32 months (range 9-52)]. Renal and patient survivals were longer in patients with NPHS1 mutations than in other patients. The invasive infection rate was 2.41/patient/year., Conclusions: Our study shows: (i) a survival free from ESKD in two-thirds of patients at 1 year and in one-half at 2 years and (ii) a significant reduction or even a discontinuation of albumin infusions allowing ambulatory care in a subset of patients. These results highlight the need for new therapeutic guidelines for CNS patients., (© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
43. Characterisation of health literacy strengths and weaknesses among people at metabolic and cardiovascular risk: Validity testing of the Health Literacy Questionnaire.
- Author
-
Debussche X, Lenclume V, Balcou-Debussche M, Alakian D, Sokolowsky C, Ballet D, Elsworth GR, Osborne RH, and Huiart L
- Abstract
Objectives: Health literacy refers to the ability of individuals to gain access to, use, and understand health information and services in order to maintain a good health. The assessment of health literacy profiles in a population is potentially crucial to respond to health needs. The Health Literacy Questionnaire explores nine dimensions of health literacy and has been shown to display robust psychometric properties. The aim was to test the validity of the multidimensional Health Literacy Questionnaire and to describe the health literacy profiles in a French population at risk of cardiovascular disease., Methods: Data were collected using self-administered questionnaires from 175 participants attending health education and support programmes in local associations of patients in Paris. Analysis included scale reliability, confirmatory factor analysis, and health literacy profiles via descriptive statistics., Results: In confirmatory factor analysis, the nine-factor structure was close to the original Health Literacy Questionnaire. A nine-factor confirmatory factor analysis model was fitted to the 44 items with no cross-loadings or correlated residuals allowed. Given the restricted nature of the model, the fit was satisfactory: χ
2 WLSMV (866 df) = 1383.81, p = 0.0000, comparative fit index = 0.925, Tucker-Lewis index = 0.918, root mean square error of approximation = 0.058, weighted root mean square residual = 1.175. Composite reliability ranged from 0.77 to 0.91. Among the 9 scales of the Health Literacy Questionnaire, the highest scores were found for scale 1 'Feeling understood and supported by healthcare professionals' and scale 9 'Understand health information enough to know what to do' and the lowest for scale 2 'Having sufficient information to manage my health' and scale 7 'Navigating the healthcare system'., Conclusion: The French version of the Health Literacy Questionnaire was shown to be psychometrically robust with good reliability. In the context of France, the 9 scales of Health Literacy Questionnaire allow a thorough assessment of health literacy strengths and weaknesses to respond to health literacy needs and improve the accessibility of health information and services., Competing Interests: Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.- Published
- 2018
- Full Text
- View/download PDF
44. Management of neonatal spontaneous intestinal perforation by peritoneal needle aspiration.
- Author
-
Gébus M, Michel JL, Samperiz S, Harper L, Alessandri JL, and Ramful D
- Subjects
- Birth Weight, Drainage adverse effects, Enteral Nutrition methods, Female, France, Gestational Age, Humans, Infant, Extremely Premature, Infant, Newborn, Infant, Premature, Diseases mortality, Intestinal Perforation mortality, Laparotomy adverse effects, Male, Needles, Retrospective Studies, Drainage methods, Infant, Extremely Low Birth Weight, Infant, Premature, Diseases therapy, Intensive Care Units, Neonatal, Intestinal Perforation therapy
- Abstract
Objective: To describe conservative management of spontaneous intestinal perforation (SIP) in preterm infants using peritoneal needle aspiration (PNA)., Study Design: Monocentric retrospective review of SIP cases treated primarily by PNA between 1999 and 2015 (n=31)., Results: Mean gestational age was 29.2±2.4 weeks and birthweight 1149±428 g. SIP occurred at 3.7±2.2 days of life. PNA achieved definitive treatment in 18 patients (60%) with a mean of 1.8 (±0.8) procedures. All patients requiring more than three PNAs had secondary laparotomy. Two patients died and five presented severe cerebral lesions. Full enteral feeding was achieved 42±18 days after SIP. Intestinal morbidity included cholestasis (n=6), intestinal stricture (n=1) and growth restriction (n=22). On follow-up (n=25, median=4 years), no severe impairment was noted. Seventeen children (68%) had a normal development., Conclusion: PNA as primary therapy for SIP is a viable option, resulting in definitive treatment in 60% of cases, with limited mortality and morbidity.
- Published
- 2018
- Full Text
- View/download PDF
45. Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection.
- Author
-
Thon-Hon VG, Denizot M, Li-Pat-Yuen G, Giry C, Jaffar-Bandjee MC, and Gasque P
- Subjects
- Cell Line, Fluorescent Antibody Technique, Indirect, Gene Expression Profiling, Humans, Real-Time Polymerase Chain Reaction, Time Factors, Viral Load, Chikungunya virus immunology, Chikungunya virus pathogenicity, Fibroblasts immunology, Fibroblasts virology, Host-Pathogen Interactions, Interferon Type I immunology
- Abstract
Background: Chikungunya virus (CHIKV) is an arthritogenic member of the Alphavirus genus (family Togaviridae) transmitted by Aedes mosquitoes. CHIKV is now known to target non hematopoietic cells such as epithelial, endothelial cells, fibroblasts and to less extent monocytes/macrophages. The type I interferon (IFN) response is an early innate immune mechanism that protects cells against viral infection. Cells express different pattern recognition receptors (including TLR7 and RIG-I) to sense viruses and to induce production of type I IFNs which in turn will bind to their receptor. This should result in the phosphorylation and translocation of STAT molecules into the nucleus to promote the transcription of IFN-stimulated antiviral genes (ISGs). We herein tested the capacity of CHIKV clinical isolate to infect two different human fibroblast cell lines HS 633T and HT-1080 and we analyzed the resulting type I IFN innate immune response., Methods: Indirect immunofluorescence and quantitative RT-PCR were used to test for the susceptibility of both fibroblast cell lines to CHIKV., Results: Interestingly, the two fibroblast cell lines HS 633T and HT-1080 were differently susceptible to CHIKV infection and the former producing at least 30-fold higher viral load at 48 h post-infection (PI). We found that the expression of antiviral genes (RIG-I, IFN-β, ISG54 and ISG56) was more robust in the more susceptible cell line HS 633T at 48 h PI. Moreover, CHIKV was shown to similarly interfere with the nuclear translocation of pSTAT1 in both cell lines., Conclusion: Critically, CHIKV can control the IFN response by preventing the nuclear translocation of pSTAT1 in both fibroblast cell lines. Counter-intuitively, the relative resistance of HT-1080 cells to CHIKV infection could not be attributed to more robust innate IFN- and ISG-dependent antiviral responses. These cell lines may prove to be valuable models to screen for novel mechanisms mobilized differentially by fibroblasts to control CHIKV infection, replication and spreading from cell to cell.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.